Senate Ag Committee unanimously backs labeling requirement for lab‑cultured meat products

COLUMBIA — The Senate Agriculture and Natural Resources Committee voted unanimously to send S.103 to the full Senate with a recommendation that it pass as amended, advancing a bill that would require manufacturers to label food products derived from cell‑cultured animal tissue.

Senator Maroney, chair of the Senate Agriculture and Natural Resources Committee, opened the session and put the bill to members after Senator Kimbrell, subcommittee chair and senator from Spartanburg, summarized the measure and the subcommittee changes adopted the previous day.

The bill does not ban the sale or purchase of cell‑cultured foods, Kimbrell said. “We just want to make sure people are clear about what they're buying,” he said, describing the proposal as a consumer‑information measure rather than a prohibition. The text adopted in subcommittee assigns labeling responsibility to manufacturers and exempts ordinary retailers that do not produce house‑brand products from enforcement provisions.

The committee and proponents said the amendment was intended to avoid imposing labeling or penalty burdens on retailers that merely resell products from third‑party manufacturers. Kimbrell said the exemption does not apply to retailers that manufacture their own house‑brand items; those firms would be subject to the labeling requirement.

Members discussed the bill’s definitions. One senator raised a concern that the draft’s reference to a “biopsy of living animal cells” might not capture products derived from nonliving tissue or processed cuts. Kimbrell and other members said the subcommittee intentionally used “biopsy” rather than “sample,” and argued the term would encompass cellular material used to propagate cultured products. He also noted testimony and early research mentioned during subcommittee hearings suggesting potential public‑health questions associated with rapidly proliferating cells, saying some early studies have raised concerns about whether cell‑culture processes could affect cancer risk; he presented that as a reason for transparent labeling rather than an assertion of proven harm.

The committee record shows stakeholders engaged in the review included industry and agricultural groups and academic input; Kimbrell named the poultry federation, the cattlemen’s association, the Department of Agriculture and Clemson University among those consulted. He told the committee that retailers who spoke to staff did not oppose the amended language; manufacturers had not taken a position he reported.

Procedure and votes: the committee adopted the subcommittee amendment in full committee and then voted to move S.103 to the Senate floor with a favorable report, both actions recorded as unanimous. The committee included proxy votes noted on the record.

Why it matters: S.103 would change labeling practice for a nascent sector of food products—cell‑cultured meat—by requiring explicit disclosure on packaging when meat is produced from cultured animal cells. Supporters framed the bill as protecting consumers’ right to know the origin of products; members said the committee intended to balance disclosure with minimal disruption for retailers that do not manufacture products.

The bill now moves to the full Senate for further consideration.